Middle East Healthcare Company (Saudi German Hospital) announces the Retirement of its CEO and the Appointment of a New Acting CEO
Element List | Explanation |
---|---|
Introduction | Middle East Healthcare Company (Saudi German Hospital) announces the Board Resolution through circulation dated 21/03/1440H corresponding to 29/11/2018 accepting the retirement of the Company Chief Executive Officer Dr. Mohammed Mamoun Al-Najjar. Due to personal reasons. Dr. Mohammed Al Najjar is unable to renew his employment contract which ended on 29/11/2018. The Board of Directors takes this opportunity to express their thanks and appreciation to Dr. Mohammed Mamoun for his valuable efforts during his 13 years tenure in the company. Based on the recommendation of the NRC the Company also announces the Board of Directors Resolution on 29/11/2018 appointing Dr. Ahmed Mohamed Shebl Al-Atris as the new Acting CEO of the Company with effect from 23/03/1440H corresponding to 01/12/2018. |
Element List | Explanation |
---|---|
Appointment Type | Assignment |
Name of the Appointing CEO | Dr. Ahmed Mohamed Shebl Al-Atris |
Date of Board Appointing CEO | 2018-11-29 Corresponding to 1440-03-21 |
Start Date | 2018-12-01 Corresponding to 1440-03-23 |
CV of the Assigned Person | Dr. Shebl holds a Master degree in Medicine in Thoracic and Cardiovascular Surgery from Al-Azhar University Egypt Diploma in Hospital Management and Diploma in Healthcare Total Quality Management from the American University in Cairo Egypt. Dr. Ahmed Shebl has been with the company since 2005 and held various senior positions including the position of Hospital CEO at Saudi German Hospital Aseer starting from 2009. Prior to joining MEAHCO. Dr. Ahmed Shebl held the position of Assistant General Manager at Nasser Institute Hospital a reputed public hospital in Egypt. He has a proven track record of managing complex hospital operations and is well trained in the company systems that will ensure effective transition. |
Element List | Explanation |
---|---|
Name of Resigned CEO | Dr. Mohammed Mamoun Al-Najjar |
Accepting Resignation Date | 2018-11-29 Corresponding to 1440-03-21 |
Resignation Effective Date | 2018-11-29 Corresponding to 1440-03-21 |
Resignation Reasons | personal reasons |
Comments